MedImmune and Manchester announce partnership to advance protein formulation

February 04, 2015

MedImmune, the global biologics research and development arm of AstraZeneca, and The University of Manchester have entered into a new research collaboration to generate cutting-edge protein formulation science.

As part of the collaboration, MedImmune will work with researchers at Manchester's Centre of Excellence in Biopharmaceuticals (COEBP) on testing and understanding the fundamental principles of protein solution behavior in order to find better ways to administer breakthrough medicines to patients.

Protein formulation is one of the critical steps in developing a protein therapeutic as a clinical product which can be administered to a patient. The four-year, multi-project collaboration will enhance research supporting new and more robust formulation approaches for antibodies and novel proteins.

MedImmune will provide funding and in-kind contributions to support several University of Manchester post-doctoral research projects addressing challenges in protein antibody formulation such as the need for ultra-high concentration liquid formulations and room temperature stable products. Specific projects will be selected by a Joint Steering Committee for their suitability in generating breakthrough research. COEBP researchers will have access to state-of-art laboratory facilities both at MedImmune's Cambridge location and The University of Manchester.

"We are excited to enter into this novel partnership with the COEBP, one of the world leading groups in biopharmaceutical development," said Gail Wasserman, Senior Vice President, Biopharmaceutical Development, MedImmune. "Through this collaboration, we hope to deepen our knowledge of the underlying protein formulation science and increase our capability to deliver formulations that will help transform the best protein molecules into the best potential treatments for patients."

This new collaboration complements AstraZeneca's existing partnership with The University of Manchester in cancer drug discovery through the Cancer Research UK Manchester Institute, as well as collaborations with the Manchester Collaborative Centre for Inflammation Research (with GlaxoSmithKline) and The North West Centre for Advanced Drug Delivery.

"We look forward to working with MedImmune to generate exciting breakthrough science together in this important research field," says Professor Alan Dickson, Head of the COEBP at The University of Manchester. "Our collaboration will form a distinct, vibrant scientific community, with the aim to formulate products more intelligently and innovatively and ensure accelerated development of key medicines."

University of Manchester

Related Protein Molecules Articles from Brightsurf:

Discovery of pH-dependent 'switch' in interaction between pair of protein molecules
All biological processes are in some way pH-dependent. Our human bodies, and those of other organisms, need to maintain specific- and constant- pH regulation in order to function.

Finally, a way to see molecules 'wobble'
Researchers at the University of Rochester and the Fresnel Institute in France have found a way to visualize those molecules in even greater detail, showing their position and orientation in 3D, and even how they wobble and oscillate.

Diets high in protein, particularly plant protein, linked to lower risk of death
Diets high in protein, particularly plant protein, are associated with a lower risk of death from any cause, finds an analysis of the latest evidence published by The BMJ today.

A new biotinylation enzyme for analyzing protein-protein interactions
Proteins play roles by interacting with various other proteins. Therefore, interaction analysis is an indispensable technique for studying the function of proteins.

Scientists synthesize novel artificial molecules that mimic a cell membrane protein
Scientists at Tokyo Institute of Technology (Tokyo Tech) recently developed an artificial transmembrane ligand-gated channel that can mimic the biological structure and function of its natural counterpart.

Resurrecting ancient protein partners reveals origin of protein regulation
After reconstructing the ancient forms of two cellular proteins, scientists discovered the earliest known instance of a complex form of protein regulation.

Colliding molecules and antiparticles
A study by Marcos Barp and Felipe Arretche from Brazil published in EPJ D shows a model of the interaction between positrons and simple molecules that is in good agreement with experimental results.

Protein aggregation: Protein assemblies relevant not only for neurodegenerative disease
Amyloid fibrils play a crucial role in neurodegenerative illnesses. Scientists from Heinrich Heine University Düsseldorf (HHU) and Forschungszentrum Jülich have now been able to use cryo-electron microscopy (cryo-EM) to decode the spatial structure of the fibrils that are formed from PI3K SH3 domains - an important model system for research.

How two water molecules dance together
Researchers have gained new insights into how water molecules interact.

Old protein, new tricks: UMD connects a protein to antibody immunity for the first time
How can a protein be a major contributor in the development of birth defects, and also hold the potential to provide symptom relief from autoimmune diseases like lupus?

Read More: Protein Molecules News and Protein Molecules Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to